L6795

LY311727

≥98% (HPLC), powder

• Empirische Formel (Hill-System): C₂₂H₂₇N₂O₅P
• CAS-Nummer: 164083-84-5
• Molekulargewicht: 430.43
• MDL-Nummer: MFCD00943218
• UNSPSC-Code: 41106300
• PubChem Substanz-ID: 329817644
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to tan
• Löslichkeit: DMSO: ≥15 mg/mL
• Ersteller: Eli Lilly
• Lagertemp.: 2-8°C
• SMILES String: CCc1c(CC(N)=O)c2cc(OCCCP(O)(O)=O)ccc2n1Cc3ccccc3
• InChI: 1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28)
• InChIKey: OPWQYOUZRHDKBR-UHFFFAOYSA-N

Beschreibung

Biochem./physiol. Wirkung

LY311727 is an orally active; potent secretory Phospholipase A2 (sPLA2; Group IIa) inhibitor.

Leistungsmerkmale und Vorteile

This compound is featured on the Phospholipase A2 page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Eli Lilly. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable